Cargando…
Drug Product Life-Cycle Management as Anticompetitive Behavior: The Case of Memantine
SUMMARY: A “product hop” involves the substitution of a new formulation of a prescription drug by a pharmaceutical manufacturer for an old version to forestall generic competition. In 2015, for example, Forest Laboratories, the brand-name drug manufacturer of memantine, an Alzheimer’s disease treatm...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398055/ https://www.ncbi.nlm.nih.gov/pubmed/27023687 http://dx.doi.org/10.18553/jmcp.2016.22.4.339 |